Law Firm Brower Piven Announces Investigation of Palomar Medical Technologies, Inc. Proposed Buyout
19 3월 2013 - 1:20AM
Business Wire
The securities litigation firm of Brower Piven, A Professional
Corporation, has commenced an investigation into possible breaches
of fiduciary duty to current shareholders of Palomar Medical
Technologies, Inc. (“Palomar” or the “Company”) (Nasdaq: PMTI) and
other violations of state law by the board of directors of Palomar
relating to the proposed buyout of the Company by Cynosure, Inc.
(“Cynosure”). The firm’s investigation seeks to determine, among
other things, whether Palomar’s board of directors breached their
fiduciary duties by failing to maximize shareholder value.
As stated in the press release announcing the proposed buyout,
Palomar shareholders will receive $13.65 for each share of Palomar
they own, which includes $6.825 per share in cash and $6.825 per
share in Cynosure common stock. However, according to Yahoo!
Finance, the high analyst price target is $14.50 per Palomar
share.
If you currently own common stock of Palomar and would like to
learn more about the investigation being conducted by Brower Piven,
you may email or call Brower Piven, who will, without obligation or
cost to you, attempt to answer your questions. You may contact
Brower Piven by email at hoffman@browerpiven.com, by calling (410)
415-6616, or at Brower Piven, A Professional Corporation, 1925 Old
Valley Road, Stevenson, Maryland 21153. Attorneys at Brower Piven
have combined experience litigating securities and other class
action cases of over 60 years.
Palomar Medical Technologies, Inc. (MM) (NASDAQ:PMTI)
과거 데이터 주식 차트
부터 8월(8) 2024 으로 9월(9) 2024
Palomar Medical Technologies, Inc. (MM) (NASDAQ:PMTI)
과거 데이터 주식 차트
부터 9월(9) 2023 으로 9월(9) 2024
Palomar Medical Technologies, Inc. (MM) (나스닥)의 실시간 뉴스: 최근 기사 0
More Brower Piven, A Professional Corporation News Articles